There is NO specific HbA1c cutoff for commercial driver's licences in Australia
The available evidence explicitly states that HbA1c should NOT be used as a criterion for licensing decisions in drivers with diabetes. 1
Why HbA1c is Not Used for Licensing Decisions
The guideline evidence is clear and emphatic: "It is ill-advised to determine risk for driving mishaps based on a driver's glycosylated hemoglobin because episodic transitions into hypoglycemia, increases the risk of driving mishaps." 1
HbA1c reflects average glucose control over 2-3 months but does not capture:
- Acute hypoglycemic episodes that pose immediate driving risk
- Hypoglycemia unawareness
- Glucose variability and sudden drops
What Actually Matters for Commercial Licensing
Individual assessment based on hypoglycemia risk is the appropriate approach, not arbitrary HbA1c thresholds. 1
Key Risk Factors That Should Trigger Evaluation:
Within the past 12 months, has the driver:
- Lost consciousness due to hypoglycemia
- Experienced hypoglycemia requiring another person's intervention
- Had hypoglycemia that interfered with driving
- Developed hypoglycemia without warning symptoms
- Had loss of visual acuity or peripheral vision
- Lost feeling in the right foot (for brake control)
- Experienced daytime sleepiness (sleep apnea screening)
Disqualifying Criteria:
Recurrent severe hypoglycemia (≥2 episodes per year) may indicate inability to safely operate a motor vehicle. 1
However, even this should allow for waivers when:
- The hypoglycemia can be explained (medication change, illness, pregnancy)
- The treating physician confirms corrective measures have been implemented
- The problem is unlikely to recur
Clinical Pitfall
Do not request or rely on HbA1c values when assessing fitness to drive. This approach is explicitly discouraged by guidelines because it fails to identify the actual safety risk (acute hypoglycemia) while potentially penalizing well-controlled patients who pose no driving hazard. The evaluation must focus on recent hypoglycemic history and diabetes-related complications that impair driving ability, assessed by the treating physician or diabetes specialist. 1